Related Experiment Video
Updated: Feb 23, 2026

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
MicroRNA-1179 inhibits glioblastoma cell proliferation and cell cycle progression via directly targeting E2F
Xiupeng Xu1, Ning Cai1, Tongle Zhi1
1Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical UniversityNanjing 210000, Jiangsu, China.
Abstract:
Glioblastoma multiforme (GBM) is an extraordinary aggressive disease that requires more effective therapeutic options. In the past few years, many microRNAs (miRNAs) have been demonstrated to have important roles in promoting GBM progression. However, little is known about the role of miR-1179 in GBM. In the present study, we found that miR-1179 was significantly downregulated in glioma tissues and cell lines. Functional experiments showed that introduction of miR-1179 dramatically suppressed GBM cell proliferation and cell cycle progression. Importantly, treatment of miR-1179 strongly inhibited tumor growth in a subcutaneous GBM model. Further studies showed that E2F transcription factor 5 (E2F5), a key transcription factor that controls cell cycle transition, was a direct target of miR-1179. Silencing of E2F5 inhibited the proliferative ability of GBM cells and induces cell cycle arrest, which were consistent with the effects of miR-1179 overexpression. More importantly, reintroduction of E2F5 into GBM cells reversed the tumor-suppressive function of miR-1179. Finally, we demonstrated that miR-1179 expression was negatively correlated with E2F5 messenger RNA (mRNA) levels in high-grade gliomas. Our findings provide new insights into the role of miR-1179 in the progression of GBM, and implicate the potential application of miR-1179 in GBM therapy.
Insights
MicroRNA-1179 (miR-1179) is downregulated in glioblastoma multiforme (GBM). Restoring miR-1179 suppresses GBM cell growth and tumor progression by targeting E2F transcription factor 5 (E2F5).
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- Glioblastoma multiforme (GBM) is a highly aggressive brain tumor with limited therapeutic options.
- MicroRNAs (miRNAs) play critical roles in GBM pathogenesis, but the function of miR-1179 remains largely unexplored.
- Identifying novel therapeutic targets is crucial for improving GBM treatment outcomes.
Purpose of the Study:
- To investigate the role of miR-1179 in glioblastoma multiforme (GBM) progression.
- To elucidate the molecular mechanisms underlying miR-1179's function in GBM.
- To assess the therapeutic potential of miR-1179 in GBM.
Main Methods:
- Quantitative real-time PCR to measure miR-1179 expression in glioma tissues and cell lines.
- In vitro functional assays (cell proliferation, cell cycle analysis) following miR-1179 introduction.
- In vivo studies using a subcutaneous GBM xenograft model to evaluate miR-1179's effect on tumor growth.
- Luciferase reporter assays and Western blotting to identify and validate E2F transcription factor 5 (E2F5) as a direct target of miR-1179.
- Rescue experiments involving E2F5 reintroduction into GBM cells.
Main Results:
- miR-1179 was significantly downregulated in glioma tissues and cell lines compared to normal controls.
- Overexpression of miR-1179 suppressed GBM cell proliferation, induced cell cycle arrest, and inhibited tumor growth in vivo.
- E2F transcription factor 5 (E2F5) was identified as a direct target of miR-1179, and its knockdown mimicked miR-1179's effects.
- Reintroduction of E2F5 reversed the tumor-suppressive effects of miR-1179.
- A negative correlation was observed between miR-1179 expression and E2F5 mRNA levels in high-grade gliomas.
Conclusions:
- miR-1179 functions as a tumor suppressor in glioblastoma multiforme (GBM).
- miR-1179 inhibits GBM progression by directly targeting E2F transcription factor 5 (E2F5), thereby regulating cell cycle progression.
- miR-1179 represents a potential therapeutic candidate for GBM treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Mitogens and the Cell Cycle
Negative Regulator Molecules

